Sofia Borges
Overview
Explore the profile of Sofia Borges including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sa D, Mendonca M, Serrao M, Sousa F, Abreu G, Henriques E, et al.
Rev Port Cardiol
. 2025 Mar;
PMID: 40057183
Introduction And Objectives: Decoding the genetic basis of coronary artery disease (CAD) through an intermediate phenotype - coronary calcification - can help us to better understand this deadly disease and...
2.
Freitas T, Costa A, Neves L, Barros C, Martins M, Freitas P, et al.
Front Neurol
. 2024 Aug;
15:1408111.
PMID: 39091979
Introduction: Ischemic stroke is a significant global health concern, with reperfusion therapies playing a vital role in patient management. Neuron-specific enolase (NSE) has been suggested as a potential biomarker for...
3.
Temtem M, Mendonca M, Santos M, Sa D, Sousa F, Freitas S, et al.
Rev Port Cardiol
. 2024 Feb;
43(8):437-444.
PMID: 38395299
Introduction And Objectives: Subjects without cardiovascular (CV) disease (CVD) may suffer from subclinical atherosclerosis, and are at increased risk for atherosclerotic CV events (ASCVE). The ESC/EAS risk SCORE was updated...
4.
Temtem M, Mendonca M, Serrao M, Santos M, Sa D, Sousa F, et al.
Eur J Prev Cardiol
. 2024 Jan;
31(6):709-715.
PMID: 38175668
Aims: Coronary artery calcium score (CACS) and polygenic risk score have been used as novel markers to predict cardiovascular (CV) events of asymptomatic individuals compared with traditional scores. No previous...
5.
Santos M, Mendonca M, Temtem M, Sa D, Sousa A, Freitas S, et al.
Rev Port Cardiol
. 2023 Jun;
42(11):907-913.
PMID: 37391023
Introduction And Objectives: Transcription factor 21 (TCF21) is a member of the basic helix-loop-helix (bHLH) transcription factor family, and is critical for embryogenesis of the heart. It regulates differentiation of...
6.
Mendonca M, Pereira A, Monteiro J, Sousa J, Santos M, Temtem M, et al.
Rev Port Cardiol
. 2022 Dec;
PMID: 36549358
The Publisher regrets that this article is an accidental duplication of an article that has already been published, 10.1016/j.repc.2022.10.005. The duplicate article has therefore been withdrawn. The full Elsevier Policy...
7.
Mendonca M, Pereira A, Monteiro J, Sousa J, Santos M, Temtem M, et al.
Rev Port Cardiol
. 2022 Oct;
42(3):193-204.
PMID: 36265803
Introduction: Coronary artery disease (CAD), characterized by an atherogenic process in the coronary arteries, is one of the leading causes of death in Madeira. The GENEMACOR (GENEs in MAdeira and...
8.
Sousa J, Mendonca M, Serrao M, Borges S, Henriques E, Freitas S, et al.
Clin Med Insights Cardiol
. 2021 Jul;
15:11795468211029244.
PMID: 34276231
Evidence points epicardial adipose tissue (EAT) as an emerging cardiovascular risk marker. Whether genetic polymorphisms linked with atherosclerosis are associated with higher EAT is still unknown. We aim to assess...
9.
Mendonca M, Henriques E, Borges S, Sousa A, Pereira A, Santos M, et al.
Genet Mol Biol
. 2021 Jun;
44(2):e20200448.
PMID: 34137427
The inclusion of a genetic risk score (GRS) can modify the risk prediction of coronary artery disease (CAD), providing an advantage over the use of traditional models. The predictive value...
10.
Pereira A, Mendonca M, Borges S, Sousa A, Freitas S, Henriques E, et al.
Genet Mol Biol
. 2018 Dec;
41(4):766-774.
PMID: 30571812
The utility of genetic risk scores (GRS) as independent risk predictors remains inconclusive. Here, we evaluate the additive value of a multi-locus GRS to the Framingham risk score (FRS) in...